Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $4.1 Million - $4.8 Million
-162,134 Reduced 13.03%
1,082,110 $30.3 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $95,896 - $110,119
-3,704 Reduced 0.3%
1,244,244 $34.5 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $1.18 Million - $1.53 Million
-45,105 Reduced 3.49%
1,247,948 $35.9 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $25,030 - $29,257
-780 Reduced 0.06%
1,293,053 $42.9 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $123,638 - $143,047
-3,423 Reduced 0.26%
1,293,833 $47.5 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $14,529 - $18,966
-348 Reduced 0.03%
1,297,256 $66.5 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $980,399 - $1.45 Million
-23,727 Reduced 1.8%
1,297,604 $76.6 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $8.38 Million - $10.8 Million
-213,529 Reduced 13.91%
1,321,331 $56.8 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $10.7 Million - $12.2 Million
-299,347 Reduced 16.32%
1,534,860 $60.1 Million
Q1 2021

Aug 13, 2021

SELL
$33.49 - $37.77 $337,646 - $380,797
-10,082 Reduced 0.55%
1,834,207 $66.5 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $60.8 Million - $77.3 Million
1,817,386 Added 6755.33%
1,844,289 $67.9 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $3.05 Million - $3.57 Million
-95,909 Reduced 78.09%
26,903 $733,000
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $3.38 Million - $4.1 Million
112,260 Added 1063.87%
122,812 $4.02 Million
Q4 2019

May 14, 2020

BUY
$32.92 - $37.36 $347,371 - $394,222
10,552 New
10,552 $413,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Stevard, LLC Portfolio

Follow Stevard, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevard, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stevard, LLC with notifications on news.